Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

ClinicalTrials.gov ID: NCT04880850

Public ClinicalTrials.gov record NCT04880850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Glargine 100 Units/mL, Both in Combination With Bolus Insulin With or Without Non-insulin Anti-diabetic Drugs, in Subjects With Type 2 Diabetes on a Basal-bolus Regimen

Study identification

NCT ID
NCT04880850
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
582 participants

Conditions and interventions

Interventions

  • Insulin aspart Drug
  • Insulin glargine Drug
  • Insulin icodec Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2021
Primary completion
Jun 15, 2022
Completion
Jun 15, 2022
Last update posted
Dec 3, 2025

2021 – 2022

United States locations

U.S. sites
52
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Lynn Institute of the Ozarks Little Rock Arkansas 72204
Anaheim Clinical Trials Anaheim California 92801
John Muir Physicians Network Concord California 94520
Valley Research Fresno California 93720
Diabetes/Lipid Mgmt & Res Ctr Huntington Beach California 92648
Valley Clinical Trials, Inc. Northridge California 91325
Clinical Trials Research_Sacramento_0 Sacramento California 95821
Diabetes Research Center Tustin California 92780
Coastal Metabolic Research Center Ventura California 93003
Diablo Clinical Research, Inc. Walnut Creek California 94598
Chase Medical Research LLC Waterbury Connecticut 06708
MedStar Diabetes Institute Washington D.C. District of Columbia 20010
Jacksonville Ctr For Clin Res Jacksonville Florida 32216
Clinical Trial Res Assoc,Inc Plantation Florida 33324
Metabolic Research Institute Inc West Palm Beach Florida 33401
Atlanta VA Medical Center Decatur Georgia 30033
Physicians Research Assoc. LLC Lawrenceville Georgia 30046
East West Med Res Inst Honolulu Hawaii 96814
Saltzer Medical Group Research Nampa Idaho 83686-6011
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383
Ochsner Clinic Foundation New Orleans Louisiana 70121
Brigham & Women's Hospital Boston Massachusetts 02115
MassResearch, LLC Waltham Massachusetts 02453
Jefferson City Medical Group, PC Jefferson City Missouri 65109
VA NEB - Western IA Health Stm Omaha Nebraska 68105
Methodist Physicians Clin Omaha Nebraska 68114
Palm Research Center Inc-Vegas Las Vegas Nevada 89148
AMC Community Endocrinology Albany New York 12206
Northport VA Medical Center_Northport_0 Northport New York 11768
SUNY Upstate Medical University Syracuse New York 13210
Southgate Medical Group, LLP West Seneca New York 14224
Mountain Diabetes & Endocrine Center Asheville North Carolina 28803
Physician's East Endocrinology Greenville North Carolina 27834
Your Diabetes Endocrine Nutrition Group, Inc. Mentor Ohio 44060
Oregon Health & Science University_Portland_0 Portland Oregon 97239
Indiana-Armstrong Endocrinology Associates Indiana Pennsylvania 15701
Prisma Health-Upstate Greenville South Carolina 29605-4254
AM Diabetes And Endocrinology Center Bartlett Tennessee 38133
WR-ClinSearch, LLC Chattanooga Tennessee 37421
Holston Medical Group Kingsport Tennessee 37660
Vanderbilt Diab Obes Clin Tri Nashville Tennessee 37212
Amarillo Med Spec LLP Amarillo Texas 79106
Texas Diab & Endo, P.A. Austin Texas 78731
Texas Diabetes & Endocrinology Austin Texas 78749
Osvaldo A. Brusco MD PA Corpus Christi Texas 78414
Baylr Sctt White Rs Inst, Endo Dallas Texas 75226
Velocity Clinical Res-Dallas Dallas Texas 75230
North Texas Endocrine Center Dallas Texas 75231
UT Southwestern Med Cntr Dallas Texas 75390-9302
Protenium Clinical Research_Hurst Fort Worth Texas 76113
DCOL Ctr for Clin Res Longview Texas 75605
Capital Clin Res Ctr,LLC Olympia Washington 98502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04880850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2025 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04880850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →